Silvana NovelliSTOP Herpes
🦠Mye: APL risk 11.6-45.7 MPN w Ruxo 3.5 to 6.9 cases per 100 patient-years. Acyclovir
🦠Lym: vaccine with anticipation, then prof w Acyclovir
🦠MM, vaccine if proteasome inh is planned, then prof w Acyclovir
🦠ASCT, SCT, CART always Acyclovir, follow protocols
https://haematologica.org/article/view/haematol.2023.284417
🦠Mye: APL risk 11.6-45.7 MPN w Ruxo 3.5 to 6.9 cases per 100 patient-years. Acyclovir
🦠Lym: vaccine with anticipation, then prof w Acyclovir
🦠MM, vaccine if proteasome inh is planned, then prof w Acyclovir
🦠ASCT, SCT, CART always Acyclovir, follow protocols
https://haematologica.org/article/view/haematol.2023.284417
